Thanks to its team Cyclomed is heavily engaged in the R&S sector, focusing on the development of new automation tecnologies in the field of radiopharmaceutical production as well as on the development of new active elements for cancer diagnostics, therapeutic control and preclinical evaluation of new drugs.
The challenge Cyclomed is facing is to have their know-how get along with medical industry, research and applications, in order to detect new diagnostic and therapeutic candidates to address unmet medical needs, thus supporting existing product areas with strategical external collaborations and developing innovative pharmaceutical forms.
